Skip to content
  • Menu
  • About

    About HRI

    HRI is a leading non-governmental organisation working to reduce the negative health, social and human rights impacts of drug use and drug policy by promoting evidence-based public health policies and practices, and human rights based approaches to drugs. Read more about HRI’s history.

    Vision and Mission

    Our vision is a world in which individuals and communities benefit from drug laws, policies and practices that promote health, dignity and human rights.

    Staff

    Meet our staff at HRI

    Governance

    HRI is governed by a nine person Board of Directors, elected for three-year terms of office by our membership at our Annual General Meetings. Read more about HRI governance.

    News and Announcements

    Read the latest announcements and updates from HRI.

    What is harm reduction?

    Harm reduction refers to policies, programmes and practices that aim to reduce the harms associated with the use of psychoactive drugs in people unable or unwilling to stop. The defining features are the focus on the prevention of harm, rather than on the prevention of drug use itself, and the focus on people who continue to use drugs.

    Harm reduction definition and principles in 11 languages

    Contact Us

    Please feel free to contact us if you have any questions or queries about our website, our work, membership or the international harm reduction conference.

    Donors

    HRI benefits from the generous support of the Open Society Foundations, the European Commission, the Elton John AIDS Foundation, the MAC AIDS Fund, UNAIDS, the World Health Organization, the UN Office on Drugs and Crime, the World Bank, The Robert Carr Networks Fund and the Swiss Government.

    Harm Reduction International Awards

    HRI presents a number of awards at outr international conference to acknowledge the contributions of outstanding groups or individuals in the field.

  • Our Work

    Evidence for advocacy

    HRI produces groundbreaking research and policy analysis informing advocacy across our sector.

    Spending where it matters

    Funding for harm reduction services is dangerously short while billions are wasted on drug enforcement. HRI works to assess resourcing needs and advocates for a reinvestment in health.

    Human rights-based policy

    Human rights abuses and drug enforcement go hand in hand. HRI challenges laws, policies and practices that generate harm.

    Sector strengthening

    HRI builds advocacy coalitions and supports emerging harm reduction networks to strengthen the international harm reduction sector.

    International conference

    Harm reduction is a global movement. Our biennial gathering is the International Harm Reduction Conference, convened by HRI.

  • Global State of Harm Reduction

    Global State of Harm Reduction

    Our flagship publication is the biennial Global State of Harm Reduction report. First published in 2008, it involves a coordinated effort across practitioners, academics, advocates and activists to map global data and responses to HIV and hepatitis C epidemics related to unsafe injecting and non-injecting drug use. It is the only report to provide an independent analysis of the state of harm reduction in the world. The information collated within the report is stored and regularly updated on an interactive e-tool for researchers and advocates.

    The Global State of Harm Reduction report is supplemented by regular thematic reports and advisories on key issues and emerging challenges. Please search our Resource Library for more information or join our e-list for regular updates.

    Interactive e-tool

    Global State of Harm Reduction’ e-tool is an interactive resource containing up-to-date information on harm reduction policy and programming around the world. Users can select countries or regions and create tables for an at-a-glance guide to the current state of harm reduction worldwide.

  • International Conferences

    International Conferences

    The 24th International Harm Reduction Conference 2015 will take place in Kuala Lumpur, Malaysia, 18–21 October, 201

    Sign up for e-updates or visit the website regularly for more information.

    You can still access the 2013 conference site for an idea of what to expect.

    Conference Archive

    Explore past international harm reduction conferences dating back to 2000.

  • Resource Library

    Resource Library

    Use our extensive resource library to search for HRI, NGO and academic reports, articles and presentations, including materials from past international conferences.

    Harm Reduction Journal

    Harm Reduction Journal, www.harmreductionjournal.com, is an open access, peer-reviewed, online journal whose focus is on the prevalent patterns of psychoactive drug use, the public policies meant to control them, and the search for effective methods of reducing the adverse medical, public health, and social consequences associated with both drugs and drug policies.

  • Support Us

    Membership & Donations

    HRI is a membership based organisation with over 8,000 members worldwide. Read more about individual and organisational membership here.

    We rely on trusts, grants, membership fees and donations to continue our work. To make a donation or pay membership fees, please use our secure payment page.

    Or why not fundraise for us with ‘Discover Adventure’?

    Contact Us

    Harm Reduction International
    Unit 2C09 Southbank Technopark
    90 London Road
    London
    SE1 6LN  

    Tel: +44(0) 207 717 1592
    Fax: +44 (0) 207 922 8822
    Email: info@ihra.net
    Join us on facebook at: Harm Reduction International
    Or join us on Twitter at: HRInews

    E-Updates

    Sign up to receive email updates, report launches, harm reduction advisories and information about the forthcoming international harm reduction conference

HRI announces new joint grant in partnership with INPUD & IDPC

Date: 22 August 2011

  • Print
  • Bookmark and Share
HRI.weblogo.2

Harm Reduction International, the International Drug Policy Consortium (IDPC) and the International Network of People who Use Drugs (INPUD) are pleased to announce the awarding of a major joint grant from the UK Department for International Development (DFID). The grant brings together these three global organisations working on drug policy and health issues to implement a joint programme of activities to support improved HIV/AIDS prevention, treatment, and care amongst injecting drug users.

Community based NGOs and drug user groups are increasingly influential in shaping and delivering the HIV/AIDS response at local and country level, but these groups need technical and capacity building support from wider regional and global networks. This grant represents a significant step forward in the capacity of international civil society to work to deliver materials, networking, training, and access to a global communication and support systems for local and national civil society. It also reflects the positive collaborative relationship between the three organisations, and the confidence of DFID in the groups’ ability to work together in advancing common goals.

Harm Reduction International is a leading international NGO promoting policies and practices that reduce the harms from drug use. IDPC is global network of NGOs and professional networks that promotes objective and open debate on drug policy issues at the national and international levels. INPUD is the international network representing issues of significance for people who use drugs.

The goal of the joint project is to create national and international legal, policy and funding environments that enable and promote the implementation and scale up of HIV prevention, treatment and care for people who inject drugs. The three organisations will work towards this goal through a collaborative and integrated programme of research, advocacy and support for strengthening regional and national civil society partners, including support for the development of drug user organisations. These activities will focus on regions where injecting drug use is already a significant factor in the HIV epidemic (Eastern Europe, former Soviet Union, Central Asia, Middle East/North Africa, South and South-East Asia), and also regions where the conditions exist for potential future epidemics (Sub-Saharan Africa, Latin America).

Due to the visionary support of DFID, who have encouraged us to work in this collaborative manner, we now have a shared platform to develop and expand our activities, and an efficient vehicle for the investment of donor resources in technical support and capacity building within the drug policy and HIV/AIDS sector. We look forward to working with civil society and government partners on this important challenge in the coming months and years.

inpud

HRI.weblogo.2

IDPC